NYSE: USPH · Medical Care Facilities
U.S. Physical Therapy (USPH) fair value: undervalued or overvalued?
As of 14 Nov 2026, Faircurve's model values U.S. Physical Therapy (USPH) at $92.36 a share. The stock last closed at $99.55, which puts the model's fair value 7.2% below the price. On the model's bands that reads as Fairly valued.
Revalued . Price is the close of 16 Nov 2026. U.S. Physical Therapy, Inc.
The report adds the live price, the chart against the range the options market prices, the next earnings date and the analysts' consensus. No account needed.
This week, in three parts
What happenedThe run of 14 Nov 2026 held the fair value at $92.36, within 1% of the run of 7 Nov 2026.
What the model makes of itThe price of $99.55 is 7.2% above it: Fairly valued, on a medium evidence grade.
What's nextNext report on 24 Feb 2027. Options prices imply a move of about 10% either way over the next month. On the model's Quality Momentum list since 5 Nov 2026 (a strategy with a proving record). The next weekly run is on Saturday 21 Nov 2026.
What price range does the model give USPH?
The calibrated range for USPH over 63 trading days is $88.38 to $112.80. It sits around the last close, and its width comes from the volatility that USPH's own options imply (36% a year), calibrated weekly against realised prices (n = 8,038 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon. The fair value is the model's opinion and rides beside the range. It is not the centre of it.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $69.96 to $119.47. In 41% of the simulations the fair value came out above the price the model ran on.
Faircurve Insights · 14 Nov 2026
U.S. Physical Therapy, Inc. (USPH) operates in healthcare, within medical care facilities. Through its various subsidiaries, it manages a network of outpatient physical therapy facilities.
Faircurve's model put the fair value of USPH at $92.36 a share on 14 Nov 2026. The previous run, on 7 Nov 2026, gave $92.77, so the fair value moved -0.4%. The range over 63 trading days runs from $88.38 to $112.80. It is built around the price from the volatility the stock's own options imply, and is calibrated weekly against realised prices across 8,038 past valuations. Ranges built this way held the price 60% of the time at this horizon. The evidence grade is Medium. It looks at input completeness, the number and agreement of comparable companies, and the width of the outcome range. It does not say whether the fair value is right.
USPH scores 62 out of 100 on the model's overall quality score, measured against comparable companies. Earnings quality scores 88 and stability scores 85. Stability reflects EBITDA margin downside volatility of 1.0 pts over five years, against a peer median of 2.1 pts. The balance sheet scores 40, with net debt to EBITDA at 3.78x against a peer median of 2.19x. The model compares USPH with Healthcare Services Group, Inc. (HCSG), Addus HomeCare Corporation (ADUS) and Hims & Hers Health, Inc. (HIMS).
Written from the figures on this page for the 14 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
The Global Pulse
Faircurve's note after each US session, in your inbox. No account needed.
When does USPH report earnings, and how has the stock reacted?
U.S. Physical Therapy's next earnings report is scheduled for 24 Feb 2027. Companies can move their dates.
On 16 Nov 2026, USPH's 30 day implied volatility worked out to a move of about 10.4% over one month, in either direction. That is a size, not a direction.
Around its last 8 reports: what the options market priced, and what followed
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across USPH's last 8 reports, ignoring direction, was 12.8%.
What the options market has priced for a month's move in USPH
How does USPH score on business quality?
U.S. Physical Therapy's overall quality score is 62 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 39 | 5.4%ROIC | 7.2% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 88 | ||
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analysts' rating changes. | 72 | 16.3%Revenue growth, trailing | 6.1% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 61 | 1.7%Net buybacks / market value | 2.1% |
| Balance sheetNet debt to EBITDA and interest coverage. | 40 | 3.78xNet debt / EBITDA | 2.19x |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 85 | 1.0 ptsEBITDA margin downside volatility, 5y | 2.1 pts |
How does USPH compare with similar companies?
The companies in medical care facilities closest to U.S. Physical Therapy in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| AMN AMN Healthcare Services, Inc. | $39.64 | $43.14 | +8.8% | Low evidence grade |
| ASTH Astrana Health, Inc. | $32.87 | $38.40 | +16.8% | Low evidence grade |
| HCSG Healthcare Services Group, Inc. | $24.86 | $24.39 | -1.9% | Fairly valued |
| ADUS Addus HomeCare Corporation | $124.61 | $133.49 | +7.1% | Fairly valued |
| MD Pediatrix Medical Group, Inc. | $31.89 | $35.38 | +10.9% | Low evidence grade |
| NHC National HealthCare Corporation | $207.19 | $249.00 | +20.2% | Low evidence grade |
| ACHC Acadia Healthcare Company, Inc. | $38.70 | $44.44 | +14.8% | Low evidence grade |
| HIMS Hims & Hers Health, Inc. | $18.56 | $21.46 | +15.6% | Undervalued |
What the comparable companies' multiples alone would give for USPH, the peer-implied price, is $50.12 a share on this run. The fair value weighs that against the company's own multiple.
All medical care facilities stocks ranked by gap to fair value
U.S. Physical Therapy at a glance
U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities.
- Market value
- $1.5B
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Revenue expected, next twelve months
- $924M
- Consensus revenue growth, next fiscal year
- +10.0%
- Analysts with estimates
- 4
- Beta to the US market
- 0.15
- First valued by Faircurve
- 11 Jul 2026
At the close of 16 Nov 2026, 56.8% of the 1,085 graded US stocks the model covers traded below the model's fair value. USPH was not among them.
How the fair value is worked out: the model prices U.S. Physical Therapy on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 7 Nov 2026 the model's fair value for USPH was $92.77. As of 14 Nov 2026 it is $92.36, a change of -0.4%. The model revalues every stock it covers each week, and again after an earnings report.
Questions about U.S. Physical Therapy's valuation
Is U.S. Physical Therapy stock undervalued or overvalued?
On Faircurve's model, USPH reads as Fairly valued as of 14 Nov 2026. The model's fair value is $92.36 a share against a last close of $99.55, a gap of -7.2%.
What is USPH's fair value?
$92.36 a share as of 14 Nov 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $69.96 to $119.47.
What price range does the model give USPH?
$88.38 to $112.80 over 63 trading days. Ranges built this way held the price 60% of the time across 8,038 past valuations, refreshed 14 Nov 2026.
When does U.S. Physical Therapy report earnings next?
The next report is scheduled for 24 Feb 2027. Companies can move their dates.
How much has USPH moved on past earnings reports?
Across its last 8 reports the median two session move was 12.8%, ignoring direction. The largest was -17.8% around the report of 6 May 2026.
How confident is the model in this valuation?
The model's evidence grade for USPH is medium. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.
The model's own ideas on USPH
The model has an idea open on USPH under Quality Momentum since 5 Nov 2026, a strategy with a proving record. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on USPH with their outcomes. A free account is enough.